Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients.Virtual KOL event will be held on Tuesday, December 12, 2023 at 7:00AM PST (4:00PM CET)MARSEILLE, France (BUSINESS WIRE) #immunotherapy Innate Pharma S.
The FDA has approved a pair of powerful new treatments for sickle cell disease.The therapies work by genetically modifying a patient's stem cells.Until now, the
Abu Dhabi Stem Cells Center Participates In International Clinical Trial For Multiple Sclerosis menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.